Douglas Tremblay, MD | Authors

Articles

Integrating Mutational Analysis Into the Clinical Management of Patients With Myelofibrosis

June 12, 2018

Myelofibrosis is a myeloproliferative neoplasm characterized by splenomegaly, progressive cytopenias, and transformation to acute myeloid leukemia. This review will describe mutations detected in myelofibrosis and discuss how to incorporate mutation information into risk stratification and therapeutic decision making for patients with myelofibrosis.